keyword
https://read.qxmd.com/read/38624263/attention-deficit-hyperactivity-disorder-and-dopamine-receptor-d4-drd4-exon-3-variable-number-of-tandem-repeats-vntr-2-repeat-allele
#1
JOURNAL ARTICLE
Larry Baum, Chi Chiu Lee, Rui Ye, Yuanxin Zhong, Se Fong Hung, Chun Pan Tang, Ting Pong Ho, James M Swanson, Robert K Moyzis, Pak-Chung Sham, Patrick Wing-Leung Leung
To investigate the association of attention-deficit/hyperactivity disorder (ADHD) with the 48-base pair (bp) variable number of tandem repeats (VNTR) in exon 3 of the dopamine receptor D4 (DRD4) gene, we genotyped 240 ADHD patients and their parents from Hong Kong. The 4R allele was most common, followed by 2R. We examined association between the 2R allele (relative to 4R) and ADHD by Transmission Disequilibrium Test (TDT). The odds ratio (OR) (95% confidence interval) was 0.90 (0.64-1.3). The p-value was 0...
April 16, 2024: Annals of Human Genetics
https://read.qxmd.com/read/38600979/parvalbumin-interneuron-deficiency-in-the-prefrontal-and-motor-cortices-of-spontaneously-hypertensive-rats-an-attention-deficit-hyperactivity-disorder-animal-model-insight
#2
JOURNAL ARTICLE
Ewelina Bogdańska-Chomczyk, Maciej Równiak, Andrew Chih-Wei Huang, Anna Kozłowska
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is characterized by impairments in developmental-behavioral inhibition, resulting in impulsivity and hyperactivity. Recent research has underscored cortical inhibition deficiencies in ADHD via the gamma-aminobutyric acid (GABA)ergic system, which is crucial for maintaining excitatory-inhibitory balance in the brain. This study explored postnatal changes in parvalbumin (PV) immunoreactivity, indicating GABAergic interneuron types, in the prefrontal (PFC) and motor (MC) cortices of spontaneously hypertensive rats (SHRs), an ADHD animal model...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38526217/ongoing-effects-of-preterm-birth-on-the-dopaminergic-and-noradrenergic-pathways-in-the-frontal-cortex-and-hippocampus-of-guinea-pigs
#3
JOURNAL ARTICLE
Roisin A Moloney, Hannah K Palliser, Rebecca M Dyson, Carlton L Pavy, Max Berry, Jonathon J Hirst, Julia C Shaw
Children born preterm have an increased likelihood of developing neurobehavioral disorders such as attention-deficit hyperactivity disorder (ADHD) and anxiety. These disorders have a sex bias, with males having a higher incidence of ADHD, whereas anxiety disorder tends to be more prevalent in females. Both disorders are underpinned by imbalances to key neurotransmitter systems, with dopamine and noradrenaline in particular having major roles in attention regulation and stress modulation. Preterm birth disturbances to neurodevelopment may affect this neurotransmission in a sexually dimorphic manner...
March 25, 2024: Developmental Neurobiology
https://read.qxmd.com/read/38471434/impaired-flexible-reward-learning-in-adhd-patients-is-associated-with-blunted-reinforcement-sensitivity-and-neural-signals-in-ventral-striatum-and-parietal-cortex
#4
JOURNAL ARTICLE
Hans-Christoph Aster, Maria Waltmann, Anika Busch, Marcel Romanos, Matthias Gamer, Betteke Maria van Noort, Anne Beck, Viola Kappel, Lorenz Deserno
Reward-based learning and decision-making are prime candidates to understand symptoms of attention deficit hyperactivity disorder (ADHD). However, only limited evidence is available regarding the neurocomputational underpinnings of the alterations seen in ADHD. This concerns flexible behavioral adaption in dynamically changing environments, which is challenging for individuals with ADHD. One previous study points to elevated choice switching in adolescent ADHD, which was accompanied by disrupted learning signals in medial prefrontal cortex...
March 1, 2024: NeuroImage: Clinical
https://read.qxmd.com/read/38467484/modafinil-an-atypical-cns-stimulant
#5
JOURNAL ARTICLE
Melinda Hersey, Gianluigi Tanda
Modafinil is a central nervous system stimulant approved for the treatment of narcolepsy and sleep disorders. Due to its wide range of biochemical actions, modafinil has been explored for other potential therapeutic uses. Indeed, it has shown promise as a therapy for cognitive disfunction resulting from neurologic disorders like ADHD, and as a smart drug in non-medical settings. The mechanism(s) of actions underlying the therapeutic efficacy of this agent remains largely elusive. Modafinil is known to inhibit the dopamine transporter, thus decreasing dopamine reuptake following neuronal release, an effect shared by addictive psychostimulants...
2024: Advances in Pharmacology
https://read.qxmd.com/read/38462065/arousal-gray-s-theory-of-anxiety-and-the-etiology-of-psychopathy
#6
REVIEW
Don C Fowles
This paper focuses on Jeffrey Gray's theory of anxiety from the perspective of Fowles' (1980) application of his work to theories of arousal, psychophysiology, and the etiology of psychopathy. Although highly influential, the concept of general arousal failed to find support in terms of between-individuals assessment with multiple physiological measures. Gray's constructs of a behavioral inhibition system (BIS) that mediates anxiety, a behavioral approach or activation system (BAS) that energizes behavior to approach rewards, and a nonspecific arousal system that energized behavior captured aspects of arousal...
March 8, 2024: Biological Psychology
https://read.qxmd.com/read/38433530/efficacy-and-safety-of-established-and-off-label-adhd-drug-therapies-for-cognitive-impairment-or-attention-deficit-hyperactivity-disorder-symptoms-in-bipolar-disorder-a-systematic-review-by-the-isbd-targeting-cognition-task-force
#7
REVIEW
Kamilla W Miskowiak, Zacharias K Obel, Riccardo Gugliemo, Caterina Del Mar Bonnin, Christopher R Bowie, Vicente Balanzá-Martínez, Katherine E Burdick, Andre F Carvalho, Annemieke Dols, Katie Douglas, Peter Gallagher, Lars V Kessing, Beny Lafer, Kathryn E Lewandowski, Carlos López-Jaramillo, Anabel Martinez-Aran, Roger S McIntyre, Richard J Porter, Scot E Purdon, Ayal Schaffer, Paul R A Stokes, Tomiki Sumiyoshi, Ivan J Torres, Tamsyn E Van Rheenen, Lakshmi N Yatham, Allan H Young, Eduard Vieta, Gregor Hasler
BACKGROUND: Abnormalities in dopamine and norepinephrine signaling are implicated in cognitive impairments in bipolar disorder (BD) and attention-deficit hyperactivity disorder (ADHD). This systematic review by the ISBD Targeting Cognition Task Force therefore aimed to investigate the possible benefits on cognition and/or ADHD symptoms and safety of established and off-label ADHD therapies in BD. METHODS: We included studies of ADHD medications in BD patients, which involved cognitive and/or safety measures...
March 3, 2024: Bipolar Disorders
https://read.qxmd.com/read/38420272/the-relationship-between-gene-slc6a3-variable-number-of-tandem-repeat-vntr-and-attention-deficit-hyperactivity-disorder
#8
JOURNAL ARTICLE
Abbas Seymari, Ashkan Naseh, Sajjad Rezaei, Zivar Salehi, Maryam Kousha
Objective : This research investigates the alleles of Variable Number of Tandem Repeats (VNTR) intron 8 of the gene SLC6A3 with attention-deficit / hyperactivity disorder (ADHD) in children and adolescents. Method : The study's target population consisted of children and adolescents referred to the specialized clinic, as well as students attending school in Rasht city during 2021-2022. A sample of 95 children between the ages of 6 and 10 with ADHD was selected as the ADHD group, and 95 healthy children were selected as the control group using purposive sampling...
January 2024: Iranian Journal of Psychiatry
https://read.qxmd.com/read/38408522/exploring-transgenerational-inheritance-in-epigenotypes-of-dat-heterozygous-rats-circadian-anomalies-and-attentional-vulnerability
#9
JOURNAL ARTICLE
Concetto Puzzo, Fabiana Festucci, Giuseppe Curcio, Antonella Gigantesco, Walter Adriani
Dopamine (DA) is mainly involved in locomotor activity, reward processes and maternal behaviors. Rats with KO gene for dopamine transporter (DAT) coding for a truncated DAT protein are in hyperdopaminergic conditions and develop stereotyped behaviors and hyperactivity. Our aim was to test the prior transgenerational modulation of wild and truncated allele as expressed in heterozygous DAT rats: specifically we addressed the possible sequelae due to genotype and gender of the ancestors, with regard to behavioral differences in F1 , F2 , F3 rats...
February 24, 2024: Behavioural Brain Research
https://read.qxmd.com/read/38396978/serotonergic-and-adrenergic-neuroreceptor-manipulation-ameliorates-core-symptoms-of-adhd-through-modulating-dopaminergic-receptors-in-spontaneously-hypertensive-rats
#10
JOURNAL ARTICLE
Sampath Madhyastha, Muddanna S Rao, Waleed M Renno
The core symptoms of attention deficit hyperactivity disorder (ADHD) are due to the hypofunction of the brain's adrenergic (NE) and dopamine (DA) systems. Drugs that enhance DA and NE neurotransmission in the brain by blocking their transporters or receptors are the current therapeutic strategies. Of late, the emerging results point out the serotonergic (5-HT) system, which indirectly modulates the DA activity in reducing the core symptoms of ADHD. On this basis, second-generation antipsychotics, which utilize 5-HT receptors, were prescribed to children with ADHD...
February 15, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38384667/using-rodent-data-to-elucidate-dopaminergic-mechanisms-of-adhd-implications-for-human-personality
#11
REVIEW
Gail Tripp, Jeff Wickens
An altered behavioral response to positive reinforcement has been proposed to be a core deficit in attention deficit hyperactivity disorder (ADHD). The spontaneously hypertensive rat (SHR), a congenic animal strain, displays a similarly altered response to reinforcement. The presence of this genetically determined phenotype in a rodent model allows experimental investigation of underlying neural mechanisms. Behaviorally, the SHR displays increased preference for immediate reinforcement, increased sensitivity to individual instances of reinforcement relative to integrated reinforcement history, and a steeper delay of reinforcement gradient compared to other rat strains...
2024: Personality Neuroscience
https://read.qxmd.com/read/38374797/-bifidobacterium-animalis-subsp-lactis-a6-attenuates-hippocampal-damage-and-memory-impairments-in-an-adhd-rat-model
#12
JOURNAL ARTICLE
Xindi Yin, Weichen Liu, Haihong Feng, Jiaqiang Huang, Qi Wang, Qi Zhang, Jingjing He, Ran Wang
Attention deficit hyperactivity disorder (ADHD) is commonly accompanied by learning and memory deficits. This study aimed to demonstrate the effects of probiotic Bifidobacterium animalis subsp. lactis A6 (BAA6) on behaviour and memory function in spontaneously hypertensive rats (SHRs). The results showed that BAA6 treatment ameliorated spatial working memory deficits and inhibited hippocampal neuron loss in SHRs. The levels of neurotransmitters such as acetylcholine, dopamine, and norepinephrine, and the brain derived neurotrophic factor increased and that of glutamate decreased in the brain tissue of SHRs after BAA6 administration...
February 20, 2024: Food & Function
https://read.qxmd.com/read/38337176/impact-of-stimulant-treatment-on-refractive-errors-and-pupil-diameter-in-attention-deficit-hyperactivity-disorder
#13
JOURNAL ARTICLE
A Eusebio López-Hernández, Carmen Miquel-López, José Javier García-Medina, Diego García-Ayuso
PURPOSE: The relationship between attention deficit hyperactivity disorder (ADHD) and visual impairment remains poorly understood, and the impact of visual impairment on the development of ADHD is uncertain. The aim of this study was to investigate the refractive profile and ocular biometric characteristics in patients diagnosed with ADHD and compare them with a control group. Additionally, we aimed to explore the potential influence of sex and medication intake. METHODS: A cohort of 100 participants, including 50 individuals with ADHD and 50 age- and sex-matched control subjects, was included in this study...
February 9, 2024: Acta Ophthalmologica
https://read.qxmd.com/read/38331128/using-caffeine-as-a-chemical-means-to-induce-flow-states
#14
REVIEW
Niklas Reich, Michael Mannino, Steven Kotler
Flow is an intrinsically rewarding state characterised by positive affect and total task absorption. Because cognitive and physical performance are optimal in flow, chemical means to facilitate this state are appealing. Caffeine, a non-selective adenosine receptor antagonist, has been emphasized as a potential flow-inducer. Thus, we review the psychological and biological effects of caffeine that, conceptually, enhance flow. Caffeine may facilitate flow through various effects, including: i) upregulation of dopamine D1/D2 receptor affinity in reward-associated brain areas, leading to greater energetic arousal and 'wanting'; ii) protection of dopaminergic neurons; iii) increases in norepinephrine release and alertness, which offset sleep-deprivation and hypoarousal; iv) heightening of parasympathetic high frequency heart rate variability, resulting in improved cortical stress appraisal, v) modification of striatal endocannabinoid-CB1 receptor-signalling, leading to enhanced stress tolerance; and vi) changes in brain network activity in favour of executive function and flow...
February 6, 2024: Neuroscience and Biobehavioral Reviews
https://read.qxmd.com/read/38326299/medicalization-of-neurodivergence-and-the-embodied-experience-of-adhd
#15
JOURNAL ARTICLE
Colin Cameron
Medicalization shapes, and in some cases legitimizes, individuals' embodied experiences even as it molds the landscape of healthcare and treatment. In this essay I provide a layered account that moves between my experiences as a neurodivergent person and academic theorizing to explore how processes of medicalization inform public discourses and personal sensemaking. In the case of ADHD, medicalization has contributed to societal narratives that focus on symptoms of hyperactivity rather than the etiology of dopamine dysregulation...
February 7, 2024: Health Communication
https://read.qxmd.com/read/38314648/phasic-dopamine-signals-are-reduced-in-the-spontaneously-hypertensive-rat-and-increased-by-methylphenidate
#16
JOURNAL ARTICLE
Yu-Ting Li, Yi-Ling Huang, Jia-Jin Jason Chen, Brian Ian Hyland, Jeffery R Wickens
The spontaneously hypertensive rat (SHR) is a selectively bred animal strain that is frequently used to model attention-deficit hyperactivity disorder (ADHD) because of certain genetically determined behavioural characteristics. To test the hypothesis that the characteristically altered response to positive reinforcement in SHRs may be due to altered phasic dopamine response to reward, we measured phasic dopamine signals in the SHRs and Sprague Dawley (SD) rats using in vivo fast-scan cyclic voltammetry. The effects of the dopamine reuptake inhibitor, methylphenidate, on these signals were also studied...
February 5, 2024: European Journal of Neuroscience
https://read.qxmd.com/read/38255250/unraveling-the-role-of-mir-200b-3p-in-attention-deficit-hyperactivity-disorder-adhd-and-its-therapeutic-potential-in-spontaneously-hypertensive-rats-shr
#17
JOURNAL ARTICLE
Tung-Ming Chang, Hsiu-Ling Lin, Chih-Chen Tzang, Ju-An Liang, Tsai-Ching Hsu, Bor-Show Tzang
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder in children with unknown etiology. Impaired learning ability was commonly reported in ADHD patients and has been associated with dopamine uptake in the striatum of an animal model. Another evidence also indicated that micro-RNA (miR)-200b-3p is associated with learning ability in various animal models. However, the association between miR-200b-3p and ADHD-related symptoms remains unclear. Therefore, the current study investigated the role of miR-200b-3p in ADHD-related symptoms such as inattention and striatal inflammatory cytokines...
January 10, 2024: Biomedicines
https://read.qxmd.com/read/38249320/viloxazine-increases-extracellular-concentrations-of-norepinephrine-dopamine-and-serotonin-in-the-rat-prefrontal-cortex-at-doses-relevant-for-the-treatment-of-attention-deficit-hyperactivity-disorder
#18
JOURNAL ARTICLE
Jennie Garcia-Olivares, Brittney Yegla, Frank P Bymaster, Jami Earnest, Jennifer Koch, Chungping Yu, Jonathan Rubin
BACKGROUND: Viloxazine ER (viloxazine extended-release capsules; Qelbree® ), a nonstimulant attention-deficit/hyperactivity disorder (ADHD) treatment, has known activity as a norepinephrine (NE) transporter (NET) inhibitor. In vitro studies have also shown direct pharmacological effects on specific serotonin (5-HT) receptors, but not on the serotonin transporter (SERT). An in vivo microdialysis study in rats showed viloxazine (50 mg/kg i.p.) increased extracellular 5-HT, NE, and dopamine (DA) in the prefrontal cortex (PFC), a key brain region in ADHD pathology...
2024: Journal of Experimental Pharmacology
https://read.qxmd.com/read/38246729/impaired-monoamine-neural-system-in-the-mpfc-of-shrsp-ezo-as-an-animal-model-of-attention-deficit-hyperactivity-disorder
#19
JOURNAL ARTICLE
Naoya Suzuki, Sachiko Hiraide, Hiroki Shikanai, Takeru Isshiki, Taku Yamaguchi, Takeshi Izumi, Kenji Iizuka
Attention-deficit/hyperactivity disorder (ADHD) is the most common childhood-onset psychiatric disorder. We investigated the effects of systemic administration of monoamine reuptake inhibitors on long-term potentiation (LTP) formation and monoamine release in the medial prefrontal cortex (mPFC) of the stroke-prone spontaneously hypertensive rat (SHRSP)/Ezo, an animal model of ADHD, and its genetic control, Wistar Kyoto (WKY)/Ezo, to elucidate the functional changes in the mPFC monoamine neural system. Methylphenidate (dopamine (DA) and noradrenaline (NA) reuptake inhibitor) and desipramine (NA reuptake inhibitor) improved LTP formation defects in the mPFC of SHRSP/Ezo, suggesting that NA or both DA and NA are required for improvement of impaired LTP...
February 2024: Journal of Pharmacological Sciences
https://read.qxmd.com/read/38225724/comprehensive-metabolic-investigation-of-dopamine-reuptake-inhibitor-hdmp-28-in-equine-liver-microsomes-and-cunninghamella-elegans-for-doping-control
#20
JOURNAL ARTICLE
Meleparappil Muhammed Ajeebsanu, Michael Benedict Subhahar, Abdul Khader Karakka Kal, Moses Philip, Zubair Perwad, Tajudheen Kunhamu Karatt, Fatma Mohammed Graiban, Marina Joseph, Shantymol V Jose
A dopamine reuptake inhibitor is a type of medication or substance that works by blocking the reuptake of dopamine in the brain. Dopamine reuptake inhibitors offer multiple effects, including increased alertness, improved mood, and therapeutic potential for conditions like depression, ADHD, and Parkinson's disease. HDMP-28, or methylnaphthidate, is a potent synthetic stimulant from the phenyltropane class. It surpasses methylphenidate in both dopamine reuptake inhibition and half-life. As a dopamine reuptake inhibitor, it boosts dopamine levels by hindering reuptake into nerve cells, resulting in heightened stimulation and increased energy...
January 15, 2024: Drug Testing and Analysis
keyword
keyword
114746
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.